Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367303669> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- W4367303669 abstract "<h3>Objective:</h3> To assess clinical and electrographic outcomes in patients receiving dual anti-glutamatergic therapy in status epilepticus. <h3>Background:</h3> Status epilepticus continues to be a challenging neurological emergency with high morbidity and mortality. To our knowledge, this is the first case series describing EEG patterns and clinical outcomes in patients treated with Ketamine and Perampanel concomitantly. <h3>Design/Methods:</h3> Retrospectively analyzed records of 25 patients treated with IV Ketamine for Status Epilepticus (SE), Refractory SE (RSE), and Super RSE (SRSE) between January 2019 and January 2022. RSE and SRSE are defined per the new classification/nomenclature. The following parameters were analyzed: Modified Rankin Scale (mRS) at admission and discharge, days on IV ketamine, time to resolution of status epilepticus, presence, or absence of burst suppression after initiating treatment and presence of beta pattern and its sustainability on EEG after treatment. We compared these parameters in patients who received Perampanel concomitantly with Ketamine to those who didn’t. <h3>Results:</h3> 21 out of 25 patients were treated with ketamine and other agents, and 4 patients with Ketamine and Perampanel. The incidence of beta pattern appearance on EEG after starting patients on Ketamine and Perampanel was achieved in all 4 patients (100%) in comparison to (61.9%) in Ketamine-only group. Burst suppression pattern was recorded in 75% of patients treated with Ketamine and Perampanel compared to 28.5% in the other. The time to resolution of status epilepticus was significantly shorter in Ketamine-only group. The average number of days on IV anesthetic was slightly lower in patient treated with concomitant Perampanel. The average increase in mRS was also lower in the group of interest. <h3>Conclusions:</h3> Dual anti-glutamatergic therapy could provide a favorable approach to treating status epilepticus, which yet needs to be further investigated through larger randomized control studies. <b>Disclosure:</b> Dr. Souidan has nothing to disclose. Prof. ANDRADE MACHADO has nothing to disclose. Dr. Lagnf has nothing to disclose. Dr. Pokharel has nothing to disclose. Dr. Elsayed has nothing to disclose." @default.
- W4367303669 created "2023-04-29" @default.
- W4367303669 creator A5024894441 @default.
- W4367303669 creator A5054876931 @default.
- W4367303669 creator A5066897177 @default.
- W4367303669 creator A5070014030 @default.
- W4367303669 creator A5076999210 @default.
- W4367303669 date "2023-04-25" @default.
- W4367303669 modified "2023-09-25" @default.
- W4367303669 title "Dual antiglutamatergic treatment in patients with status epilepticus: a case series (P9-1.008)" @default.
- W4367303669 doi "https://doi.org/10.1212/wnl.0000000000203265" @default.
- W4367303669 hasPublicationYear "2023" @default.
- W4367303669 type Work @default.
- W4367303669 citedByCount "0" @default.
- W4367303669 crossrefType "proceedings-article" @default.
- W4367303669 hasAuthorship W4367303669A5024894441 @default.
- W4367303669 hasAuthorship W4367303669A5054876931 @default.
- W4367303669 hasAuthorship W4367303669A5066897177 @default.
- W4367303669 hasAuthorship W4367303669A5070014030 @default.
- W4367303669 hasAuthorship W4367303669A5076999210 @default.
- W4367303669 hasConcept C118552586 @default.
- W4367303669 hasConcept C2777341932 @default.
- W4367303669 hasConcept C2778186239 @default.
- W4367303669 hasConcept C2780795376 @default.
- W4367303669 hasConcept C2780836401 @default.
- W4367303669 hasConcept C42219234 @default.
- W4367303669 hasConcept C71924100 @default.
- W4367303669 hasConceptScore W4367303669C118552586 @default.
- W4367303669 hasConceptScore W4367303669C2777341932 @default.
- W4367303669 hasConceptScore W4367303669C2778186239 @default.
- W4367303669 hasConceptScore W4367303669C2780795376 @default.
- W4367303669 hasConceptScore W4367303669C2780836401 @default.
- W4367303669 hasConceptScore W4367303669C42219234 @default.
- W4367303669 hasConceptScore W4367303669C71924100 @default.
- W4367303669 hasLocation W43673036691 @default.
- W4367303669 hasOpenAccess W4367303669 @default.
- W4367303669 hasPrimaryLocation W43673036691 @default.
- W4367303669 hasRelatedWork W2069550437 @default.
- W4367303669 hasRelatedWork W2269328288 @default.
- W4367303669 hasRelatedWork W2985476322 @default.
- W4367303669 hasRelatedWork W2998058373 @default.
- W4367303669 hasRelatedWork W3003328575 @default.
- W4367303669 hasRelatedWork W3022106777 @default.
- W4367303669 hasRelatedWork W3160316901 @default.
- W4367303669 hasRelatedWork W3205947137 @default.
- W4367303669 hasRelatedWork W4286592420 @default.
- W4367303669 hasRelatedWork W4288033808 @default.
- W4367303669 isParatext "false" @default.
- W4367303669 isRetracted "false" @default.
- W4367303669 workType "article" @default.